Search Results

Breakthrough Research Reveals Novel Therapeutic Approaches for Inflammatory Bowel Disease Management

Patients With Moderate-to-Severe Ulcerative Colitis May Find Significant Relief as groundbreaking research introduces Tulisokibart as a potential new treatment.

Research from Max Delbrück Center and Charité - Universitätsmedizin Berlin suggests new therapeutic approaches to prevent disease progression to cancer

Phase II Study Shows That Monoclonal Antibody Treatment Developed by Cedars-Sinai Researchers Is Effective for Moderate to Severe Ulcerative Colitis

Amrinder Singh Sidhu and B. M. Sharma, held the hospital responsible for prescribing milk to a patient with ulcerative colitis, which could seriously harm his health

The study evaluated the potential of two biomarkers, c-myc and p-GR, in wound tissue to predict healing outcomes in diabetic foot ulcers.